Stock Taper
SCREENER COMPARE ANY 2 STOCKS
ATRC
ATRICURE, INC.
NASDAQ
$48.54
▼ DOWN 1.48% (-0.73)

KEY STATISTICS

Market Cap$2.47 B
52w High$49.98
52w Low$25.36
Dividend Yield—
Frequency—
P/E1507.45
Volume390.63K
Shares Out.50.87M

COMPANY

LEADERSHIP

Michael H. Carrel
CHIEF EXECUTIVE
Michael H. Carrel

COMPENSATION 2026

Salary$824,417
Stock Awards$9,350,144
Incentive Plan Pay$882,039
All Other Comp.$13,800
Total$11,070,400

ABOUT

SECTOR
Healthcare
WENT PUBLIC
August 5, 2005
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
1,350

PRICE TARGET

Target High$60.00
Target Low$50.00
Target Median$55.00
Target Consensus$54.40

UPCOMING EARNINGS

DateNov 4, 2026
DayWednesday
Rev. Est.$151.18M
NOV
4
WED

PRICE

$48.54 ▼ DOWN 1.48% (−$0.73)
$48.50$49.00$49.50$50.009:30 AM10:35 AM11:40 AM12:45 PM1:49 PM2:54 PM3:59 PM48.54

About AtriCure, Inc.

https://www.atricure.com ↗

AtriCure, Inc. develops and sells surgical ablation devices and systems for cardiac tissue and nerve treatment worldwide, including ablation tools, cryoablation systems, and tissue closure devices.

INDUSTRY

Medical - Instruments & Supplies

A PRODUCT ATRICURE, INC. IS KNOWN FOR

AtriClip PRO-Mini® LAA Exclusion System
AtriClip PRO-Mini® LAA Exclusion System

The AtriClip PRO-Mini, FDA-cleared in 2025, is the smallest minimally invasive LAA management device, improving visualization and precision to reduce stroke risk in atrial fibrillation patients.

COMPETITORS

COMPETITOR
ABT COMPARE
BSX COMPARE
JNJ COMPARE
MDT COMPARE
TFX COMPARE

Revenue by Products

IconPRODUCTFY2022FY2023FY2024FY2025
Shipping and Handling$1.5M $1.86M ▲$2.42M ▲$2.45M ▲

Revenue by Geography

MapREGIONQ3-2025Q4-2025Q1-2026Q2-2026
U S$109.31M $114.33M ▲$116.2M ▲$125.59M ▲
NonUS$24.96M $26.17M ▲$25.04M ▼$28.02M ▲

ETFS HOLDING THIS STOCK

ETFS HOLDING
146
LISTED HERE
26
RANKED BY POSITION SIZE
VTI
0.00% · 1.5M
IWM
0.08% · 1.3M
FESM
0.40% · 539.6K
SCHA
0.05% · 239.6K
DFMC
0.10% · 167.5K
PSC
0.24% · 137.7K
XHE
2.63% · 96.7K
FYC
0.23% · 66.6K
GSSC
0.27% · 59.9K
PRFZ
0.08% · 49.1K
XRS2.F
0.08% · 45.7K
HAPS
1.11% · 39.9K
RSSL
0.08% · 23.8K
ETHO
0.49% · 19.6K
AI
AIMS
0.92% · 16.8K
WSCSRI.SW
0.09% · 14.8K
BBSC
0.09% · 13.7K
RTWP.L
0.14% · 6.2K
FLQS
0.34% · 3.3K
URTY
0.03% · 2.0K
HART
0.50% · 1.3K
BUYO
0.32% · 1.1K
SYZ
0.05% · 743
AVUS
0.00% · 696
QSML
0.24% · 602
ADDS
0.23% · 319

INSTITUTIONAL OWNERSHIP

SHARES OWNED
71.63%
HOLDERS
369
TOP 12 OF 369 · RANKED BY POSITION SIZE
Vanguard Group Inc
4.9M sh · $193.99M
Blackrock Inc.
4.6M sh · $105.1M
Blackrock, Inc.
4.5M sh · $125.2M
Wellington Management Group Llp
4.3M sh · $151.3M
Alliancebernstein L.P.
3.6M sh · $140.98M
Hood River Capital Management LLC
3.1M sh · $88.94M
Macquarie Group Ltd
2.3M sh · $80.7M
MM
Macquarie Management Holdings, Inc.
2.0M sh · $80.65B
Rs Investment Management Co LLC
2.0M sh · $28.65M
Champlain Investment Partners, LLC
2.0M sh · $69.73M
Goldman Sachs Group Inc
1.7M sh · $47.56M
Marshall Wace, Llp
1.5M sh · $41.87M

RATINGS SNAPSHOT

Overall rating: B

DCFROEROAD/EP/EP/B
Discounted Cash Flow4
Return On Equity3
Return On Assets3
Debt To Equity3
Price To Earnings1
Price To Book3
Overall Score3

TRADES BY CONGRESS

HOUSE TRADES
Gilbert Cisneros
Gilbert Cisneros
Purchase
2026-03-03
 Josh Gottheimer
Josh Gottheimer
Purchase
2024-07-19

INSIDER TRADES

★
OFFICER: CHIEF LEGAL OFFICER
Dahlquist Karl S.
Sale · 9.4K shares
2026-08-24
★
DIRECTOR
Yuen Maggie
Sale · 3.5K shares
2026-08-05
★
DIRECTOR
Prange Karen
Sale · 3.6K shares
2026-08-05
★
DIRECTOR, OFFICER: PRESIDENT, CEO, & DIRECTOR
CARREL MICHAEL H
Sale · 700 shares
2026-07-30

MOST RECENT ANALYST GRADES

GRADE SUMMARY
BUY 4
MARKET OUTPERFORM 1
PERFORM 1
OVERWEIGHT 1
7 GRADES IN THE LAST 12 MONTHS
BTIG BUY UBS BUY Canaccord Genuity BUY Citizens MARKET OUTPERFORM Oppenheimer PERFORM Needham BUY JP Morgan OVERWEIGHT

SECTORS PEERS

PEERPRICE
TXG$61.54COMPARE
NVCR$17.82COMPARE
IMCR$36.62COMPARE
LMAT$80.45COMPARE
BLFS$36.38COMPARE
AZTA$32.95COMPARE
KMTS$25.64COMPARE
XERS$8.48COMPARE